Schizophrenia in childhood and adolescence

Neuroendocrinology Letters

Volumn 29, Issue 6, 2008, Pages 831-836

  Malá, Eva ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cerebellar cognitive affective syndrome; Childhood and adolescence schizophrenia; Cognitive function; Family trait marker of schizophrenia disorder; Social brain

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; GLUTAMIC ACID; NEUROTRANSMITTER;

ADOLESCENT; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CHILD; COGNITION; COGNITIVE DEFECT; DISORIENTATION; DOPAMINERGIC NERVE CELL; EMOTIONAL DISORDER; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC VARIABILITY; HEADACHE; HUMAN; INSOMNIA; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; NEUROTRANSMISSION; ONSET AGE; PATHOGENESIS; PREVALENCE; PROGNOSIS; PSYCHOLOGIC TEST; REVIEW; SCHIZOPHRENIA; SOCIAL DISABILITY; SPEECH DISORDER;

EID: 59849115615     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Allin M, Mastsumoto H, Santhouse AM et al (2001).Cognitive and motor function and the size of cerebellum in adolescents born very pre-term. Brain.124: 60-66.
2. Bromley E. (2007). Clinicians' Concepts of the Cognitive Deficits of Schizophrenia. Schizophrenia Bulletin. 33(3): 648-651.
3. Burns JK. (2004). An evolutionary theory of schizophrenia: cortical connectivity, metapresentation, and the social brain. Behav Brain Sci. 27/6/851-85.
4. Cannon M, Dean K (2004). Childhood similarities and differences between schizophrenia anfd bipolar disorder. In: Schizophrenia: challenging the orthodox, edited by Mc Donald C, Schultze K, Murray RM, et al, Taylor, Francis UK. pp. 205-211.
5. Dunbar RI, Shultz S (2007) Evolution in the Social Brain Science Vol. 317. no. 5843, pp. 1344-1347.
6. Eckert MA, Leonard CM, Richards TL, et al, (2003).Anatomical correlates of dyslexia: frontal and cerebellar findings. Brain. 126: 482-494.
7. Frangou S, Chitins X, Williams SC (2004). Mapping IQ and gray matter density in healthy young people. Neuroimage. 23(8): 800-805.
8. Gogtay N, Greenstein D, Lenane M, et al, (2007). Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia. Arch-Gen-Psychiatry. 64(7): 772-80.
9. Hashimoto T, Arion D, Unger T,(2008). Alterations in GABA related transcriptosome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry. 13: 147-161.
10. Malá E (2005). Schizofrenie v dětství a adolescenci. Praha (ČR): Grada.
11. Mravec M,(2008). Mozočok: Štruktura, funkcie a jeho úloha při neuropsychiatrických ochoreniach. Psychiatrie. 12 (1): 17-26.
12. Nugent T, Herman DH, Ordonez A, et al, (2007). Dynamic mapping of hippocampal development in childhood onset schizophrenia. Schizophr-Res. 90 (1-3): 62-70.
13. Ross RG, Wagner B, Heinlein S.et al, (2008). The stability of inhibitory and working memory deficits in children and adolescents who are children of parents with schizophrenia. Schizophr-Bull. 34 (1): 47-51..
14. Schwartz-Stay O, Apter A, Zalsman G, (2006). Depression, suicidal behavior and insight in adolescents with schizophrenia. Eur-Child-Adolesc-Psychiatry. 15 (6): 352-9.
15. Št'astný F, Balcar JV, (2008).Schizofrenie jako genetická porucha synaptického spojení. Psychiatrie 12 (Suppl.2): 29-38.
16. Volavka J,(2008). Vztah mezi COMT a agresí: pohyblivý cíl? Psychiatrie 12 (2): 72-73.
17. Voltz HP, Gase C, Hager F, et al, (1997). Brain Activation During Five Stimulation with the Wisconsin Card Sorting Test A Functional MRI Study of Healthy Volunteers and Schizophrenics. Psychiatry Res. Neuroimaging Sec 75: 145-157.
18. Vondráček V (1967). Speciální psychiatrie. Praha (ČR): SPN Publishers.
19. Whitford TJ, Grieve SM, Farrow TF, et al, (2007).Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am-J-Psychiatry. 164 (7): 1082-9.
20. Whyte MC, Whalley HC, Simonotto E, (2006). Event-related fMRI of word classification and successful word recognition in subjects at genetically enhanced risk of schizophrenia. Psychol-Med. 36 (10): 1427-39.